Global Spinal Muscular Atrophy Medicine Sales Market Report 2018

June 2018 | 115 pages | ID: G721D1A76A9EN
QYResearch

Abstracts

This report studies the global Spinal Muscular Atrophy Medicine market status and forecast, categorizes the global Spinal Muscular Atrophy Medicine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Spinal Muscular Atrophy Medicine market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major players covered in this report

• Astellas Pharma Inc.
• AveXis, Inc.
• Bioblast Pharma Ltd.
• Cytokinetics, Inc. 24
• F. Hoffmann-La Roche Ltd.
• Genethon
• Genzyme Corporation
• GMP-Orphan SAS
• Ionis Pharmaceuticals, Inc.
• Longevity Biotech, Inc
• Neurodyn Inc.
• Neurotune AG
• Novartis AG
• Sarepta Therapeutics, Inc.
• Voyager Therapeutics, Inc.
• Vybion, Inc.
• WAVE Life Sciences Ltd.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• LMI-070
• ND-602
• NT-1654
• Nusinersen
• NXD-30001
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

The study objectives of this report are:

• To analyze and study the global Spinal Muscular Atrophy Medicine sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Spinal Muscular Atrophy Medicine players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Spinal Muscular Atrophy Medicine are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Spinal Muscular Atrophy Medicine Manufacturers
Spinal Muscular Atrophy Medicine Distributors/Traders/Wholesalers
Spinal Muscular Atrophy Medicine Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Spinal Muscular Atrophy Medicine market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Spinal Muscular Atrophy Medicine Sales Market Report 2018

1 SPINAL MUSCULAR ATROPHY MEDICINE MARKET OVERVIEW

1.1 Product Overview and Scope of Spinal Muscular Atrophy Medicine
1.2 Classification of Spinal Muscular Atrophy Medicine by Product Category
  1.2.1 Global Spinal Muscular Atrophy Medicine Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Spinal Muscular Atrophy Medicine Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 LMI-070
  1.2.4 ND-602
  1.2.5 NT-1654
  1.2.6 Nusinersen
  1.2.7 NXD-30001
  1.2.8 Others
1.3 Global Spinal Muscular Atrophy Medicine Market by Application/End Users
  1.3.1 Global Spinal Muscular Atrophy Medicine Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Others
1.4 Global Spinal Muscular Atrophy Medicine Market by Region
  1.4.1 Global Spinal Muscular Atrophy Medicine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Spinal Muscular Atrophy Medicine Status and Prospect (2013-2025)
  1.4.3 Europe Spinal Muscular Atrophy Medicine Status and Prospect (2013-2025)
  1.4.4 China Spinal Muscular Atrophy Medicine Status and Prospect (2013-2025)
  1.4.5 Japan Spinal Muscular Atrophy Medicine Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Spinal Muscular Atrophy Medicine Status and Prospect (2013-2025)
  1.4.7 India Spinal Muscular Atrophy Medicine Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Spinal Muscular Atrophy Medicine (2013-2025)
  1.5.1 Global Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2025)
  1.5.2 Global Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2025)

2 GLOBAL SPINAL MUSCULAR ATROPHY MEDICINE COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Spinal Muscular Atrophy Medicine Market Competition by Players/Suppliers
  2.1.1 Global Spinal Muscular Atrophy Medicine Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Spinal Muscular Atrophy Medicine Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Spinal Muscular Atrophy Medicine (Volume and Value) by Type
  2.2.1 Global Spinal Muscular Atrophy Medicine Sales and Market Share by Type (2013-2018)
  2.2.2 Global Spinal Muscular Atrophy Medicine Revenue and Market Share by Type (2013-2018)
2.3 Global Spinal Muscular Atrophy Medicine (Volume and Value) by Region
  2.3.1 Global Spinal Muscular Atrophy Medicine Sales and Market Share by Region (2013-2018)
  2.3.2 Global Spinal Muscular Atrophy Medicine Revenue and Market Share by Region (2013-2018)
2.4 Global Spinal Muscular Atrophy Medicine (Volume) by Application

3 UNITED STATES SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  3.1.1 United States Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2018)
  3.1.2 United States Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  3.1.3 United States Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
3.2 United States Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Players (2013-2018)
3.3 United States Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type (2013-2018)
3.4 United States Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application (2013-2018)

4 EUROPE SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  4.1.1 Europe Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2018)
  4.1.2 Europe Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
4.2 Europe Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application (2013-2018)

5 CHINA SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

5.1 China Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  5.1.1 China Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2018)
  5.1.2 China Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  5.1.3 China Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
5.2 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Players (2013-2018)
5.3 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type (2013-2018)
5.4 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application (2013-2018)

6 JAPAN SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  6.1.1 Japan Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2018)
  6.1.2 Japan Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
6.2 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  7.1.1 Southeast Asia Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
7.2 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application (2013-2018)

8 INDIA SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

8.1 India Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  8.1.1 India Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2018)
  8.1.2 India Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  8.1.3 India Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
8.2 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Players (2013-2018)
8.3 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type (2013-2018)
8.4 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL SPINAL MUSCULAR ATROPHY MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Astellas Pharma Inc.
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 AveXis, Inc.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Bioblast Pharma Ltd.
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Cytokinetics, Inc.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 F. Hoffmann-La Roche Ltd.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Genethon
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Genethon Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Genzyme Corporation
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 GMP-Orphan SAS
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Ionis Pharmaceuticals, Inc.
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Longevity Biotech, Inc
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 Neurodyn Inc.
9.12 Neurotune AG
9.13 Novartis AG
9.14 Sarepta Therapeutics, Inc.
9.15 Voyager Therapeutics, Inc.
9.16 Vybion, Inc.
9.17 WAVE Life Sciences Ltd.

10 SPINAL MUSCULAR ATROPHY MEDICINE MAUFACTURING COST ANALYSIS

10.1 Spinal Muscular Atrophy Medicine Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
10.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Spinal Muscular Atrophy Medicine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL SPINAL MUSCULAR ATROPHY MEDICINE MARKET FORECAST (2018-2025)

14.1 Global Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Spinal Muscular Atrophy Medicine Price and Trend Forecast (2018-2025)
14.2 Global Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Spinal Muscular Atrophy Medicine Sales Forecast by Type (2018-2025)
  14.3.2 Global Spinal Muscular Atrophy Medicine Revenue Forecast by Type (2018-2025)
  14.3.3 Global Spinal Muscular Atrophy Medicine Price Forecast by Type (2018-2025)
14.4 Global Spinal Muscular Atrophy Medicine Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES
Figure Product Picture of Spinal Muscular Atrophy Medicine
Figure Global Spinal Muscular Atrophy Medicine Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (Product Category) in 2017
Figure LMI-070 Product Picture
Figure ND-602 Product Picture
Figure NT-1654 Product Picture
Figure Nusinersen Product Picture
Figure NXD-30001 Product Picture
Figure Others Product Picture
Figure Global Spinal Muscular Atrophy Medicine Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Spinal Muscular Atrophy Medicine by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Spinal Muscular Atrophy Medicine Market Size (Million USD) by Regions (2013-2025)
Figure United States Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers
Figure 2017 Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers
Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Spinal Muscular Atrophy Medicine Revenue Share by Players
Table 2017 Global Spinal Muscular Atrophy Medicine Revenue Share by Players
Table Global Spinal Muscular Atrophy Medicine Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Sales Growth Rate by Type (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Revenue Growth Rate by Type (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Sales Share by Region (2013-2018)
Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Sales Growth Rate by Region in 2017
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Revenue Growth Rate by Region in 2017
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region in 2017
Table Global Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Spinal Muscular Atrophy Medicine Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Application (2013-2018)
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share by Application (2013-2018)
Figure United States Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Players (2013-2018)
Table United States Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players (2013-2018)
Figure United States Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players in 2017
Table United States Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table United States Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure United States Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table United States Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018)
Table United States Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure United States Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure Europe Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players (2013-2018)
Figure Europe Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players in 2017
Table Europe Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure Europe Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table Europe Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure Europe Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure China Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Players (2013-2018)
Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players in 2017
Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018)
Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure Japan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players in 2017
Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players in 2017
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure India Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Players (2013-2018)
Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Players in 2017
Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018)
Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table AveXis, Inc. Basic Information List
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table Bioblast Pharma Ltd. Basic Information List
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table Cytokinetics, Inc. 24 Basic Information List
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table Genethon Basic Information List
Table Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genethon Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure Genethon Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018
Figure Genethon Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table Genzyme Corporation Basic Information List
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table GMP-Orphan SAS Basic Information List
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table Ionis Pharmaceuticals, Inc. Basic Information List
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table Longevity Biotech, Inc Basic Information List
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Growth Rate (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Global Market Share (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Revenue Global Market Share (2013-2018)
Table Neurodyn Inc. Basic Information List
Table Neurotune AG Basic Information List
Table Novartis AG Basic Information List
Table Sarepta Therapeutics, Inc. Basic Information List
Table Voyager Therapeutics, Inc. Basic Information List
Table Vybion, Inc. Basic Information List
Table WAVE Life Sciences Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Spinal Muscular Atrophy Medicine
Figure Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
Figure Spinal Muscular Atrophy Medicine Industrial Chain Analysis
Table Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Players in 2017
Table Major Buyers of Spinal Muscular Atrophy Medicine
Table Distributors/Traders List
Figure Global Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Regions in 2025
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Regions in 2025
Figure United States Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2018-2025)
Figure China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Type (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Spinal Muscular Atrophy Medicine Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources